Difficulty: Medium
Average Score: 73%
Practice
In the development of a new drug by a pharmaceutical company, the researcher must ensure that the participants in experimental drug studies do not have unrealistic expectations of the new drug's usefulness. What will the researcher include in the design of the study to prevent bias that may occur?
Correct answer
A
Rationale
A placebo prevents bias from expectations participants can't distinguish drug from inert substance, per RCT standards (Health Canada). Approval follows trials, not design. Consent informs but doesn't blind expectations persist. Efficacy info biases if shared early. Placebos cut bias by 30-40% (e.g., BMJ), ensuring objective outcomes, making A the best choice over B, C, or D.